ArticleJournal of cancer research and clinical oncology2023
Multi-targeted tyrosine kinase inhibitor reverses resistance to immunotherapy in hepatic sarcomatoid carcinoma.
Juan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.